Literature DB >> 1820520

Susceptibility of Trichophyton rubrum to griseofulvin.

R Scholz1, W Meinhof.   

Abstract

Two hundred and seventy isolates of Trichophyton rubrum from 182 patients were subjected to susceptibility testing with griseofulvin according to Granade & Artis. A slight modification of the method concerning homogenization procedures gave better growth of controls in our investigation. In 245 cases an MIC could be determined. Among these isolates, seven strains from six patients presented MICs between 2 and 3 micrograms griseofulvin per ml, a value which, according to Artis et al., is to be considered as relatively resistant. The other isolates proved to be more susceptible to griseofulvin. Three of the patients showed no indication of therapeutic failure of griseofulvin treatment. The other three patients had onychomycoses of long standing and had been treated with griseofulvin previously with little or limited success. It is our conclusion that griseofulvin susceptibility testing is not a reliable instrument in explaining failure of griseofulvin therapy in Trichophyton rubrum mycoses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1820520     DOI: 10.1111/j.1439-0507.1991.tb00804.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  4 in total

1.  In vitro susceptibility of Trichophyton rubrum isolates to griseofulvin and tioconazole. Induction and isolation of a resistant mutant to both antimycotic drugs. Mutant of Trichophyton rubrum resistant to griseofulvin and tioconazole.

Authors:  A L Fachin; C M Maffei; N M Martinez-Rossi
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

2.  Antimycotic effectiveness against dermatophytes: comparison of two in vitro tests.

Authors:  Roberta Galuppi; Alessandra Gambarara; Cristina Bonoli; Fabio Ostanello; Maria Paola Tampieri
Journal:  Vet Res Commun       Date:  2010-06       Impact factor: 2.459

Review 3.  The dermatophytes.

Authors:  I Weitzman; R C Summerbell
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

Review 4.  Therapy and Antifungal Susceptibility Profile of Microsporum canis.

Authors:  Chioma I Aneke; Domenico Otranto; Claudia Cafarchia
Journal:  J Fungi (Basel)       Date:  2018-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.